As more people take the injectable weight-loss medication Wegovy, the FDA warns of overdose risks. Symptoms can be severe, leading to hospitalization.
Novo Nordisk provides semaglutide in preportioned pens, but many obtain it from compounding pharmacies, which require patients to measure their own doses.
Dr. Janice Jin Hwang emphasized, 'You have to know conversions, and you have to know how much to draw up,' highlighting the complexities of dosing semaglutide.
Overdoses often occur as patients using compounding pharmacies struggle with correct dosage conversions, underscoring the risks associated with self-measuring their medication.
[
Collection
]
[
|
...
]